Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers
about
Factors affecting carisoprodol metabolism in pain patients using urinary excretion data.Hydroxylation index of omeprazole in relation to CYP2C19 polymorphism and sex in a healthy Iranian populationPredictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescentsEffect of proton pump inhibitors on the serum concentrations of the selective serotonin reuptake inhibitors citalopram, escitalopram, and sertralineSex-dependent modulation of treatment response"Cocktail" approaches and strategies in drug development: valuable tool or flawed science?Gender differences in pharmacokinetics and pharmacodynamics of methadone substitution therapyThe effect of ethinyloestradiol and levonorgestrel on the CYP2C19-mediated metabolism of omeprazole in healthy female subjectsPharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects.Alterations in drug disposition during pregnancy: implications for drug therapy.Sex-specific differences in CYP450 isoforms in humans.Regulation of human CYP2C18 and CYP2C19 in transgenic mice: influence of castration, testosterone, and growth hormoneGender and interindividual variability in pharmacokinetics.Sex-specific differences in side effects of psychotropic drugs: genes or gender?Gender differences in antidepressant drug response.Pharmacokinetics and pharmacodynamics of psychotropic drugs: effect of sex.Hormonal regulation of hepatic drug biotransformation and transport systems.Gender Differences in Cardiovascular Drugs.Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine.Gender differences in the effects of cardiovascular drugs.Pharmacokinetics of omeprazole and its metabolites in three phases of menstrual cycle.Omeprazole limited sampling strategies to predict area under the concentration-time curve ratios: implications for cytochrome P450 2C19 and 3A phenotyping.Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil.Lack of weight-based dose dependency and intraindividual variability of omeprazole for CYP2C19 phenotyping.Lack of effect of Ginkgo biloba on voriconazole pharmacokinetics in Chinese volunteers identified as CYP2C19 poor and extensive metabolizers.Influence of age and gender on risperidone plasma concentrations.Effect of a triphasic oral contraceptive on drug-metabolizing enzyme activity as measured by the validated Cooperstown 5+1 cocktail.Use of omeprazole as a CYP3A probe drug: effect of sex and menstrual cycle phase on CYP3A activity in healthy Caucasian adults.Key interindividual determinants in MDMA pharmacodynamics.Sex differences in 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)-induced cytochrome P450 2D6 inhibition in humans.Discontinuation and dose adjustment of metoprolol after metoprolol-paroxetine/fluoxetine co-prescription in Dutch elderly.Effect of Conjugated Equine Estrogens on Oxidative Metabolism in Middle-aged and Elderly Postmenopausal Women
P2860
Q30746761-6411AF84-0564-4C46-995E-EF9AF61A3265Q34706677-86E08961-74C4-46F5-B343-5C25DDB71ECEQ34831800-B0AE4098-2B4B-47FF-A62A-9E307A45E31FQ34978292-91BE9DD7-C7E9-47A6-AB2B-7573DCF95AE5Q35236761-84FC398E-2595-4FE7-AB3C-A6AA6005EEFDQ35640730-D40ABDB4-D429-46C9-872E-EC14FBE0C7E7Q35698405-7758B002-50C8-420B-8373-BBE100DF310CQ35825470-CD2A8CF8-CF7C-4852-9790-7DC51C1EFBCAQ36536413-5A311E62-A875-4DF0-98DC-FCA37587E0E1Q36909328-E61B6CE5-00BE-4E61-A7E8-62002655C60FQ37181876-ABBC92B3-F359-4595-A7E3-C5B50F165E5EQ37233832-81BFC7F0-8528-4582-930E-16AF0DF8B6CBQ37550556-2D02E15B-175E-4BCC-991F-98BF66F50EE9Q37598900-D5FC165A-0A23-4B38-88F1-64A8F2157C19Q37806757-3FFFBEA5-6BC0-4400-80CB-79581A3E4525Q38078561-073E9700-0F3A-4EAF-AC4D-1941AA3F85BBQ38165145-C43FCF26-9A85-435E-AC9C-46D59AA32220Q38557955-BBEA9774-21B8-41BB-B5FA-86F8CCCD334DQ38634986-459B31A1-4CEA-4BE9-B7CA-9735C425B476Q39193538-F6E045BD-ABD5-4242-B50D-DF59991168DCQ42635992-C26ED1C9-143A-487B-9088-2D7D24D20D6FQ43626046-2C8B74A7-B4E5-4729-B550-B3BCA40A7DB8Q43979783-30058322-B960-469F-9827-3D7A51E0C621Q45022878-09E2A220-BA50-4A54-95FD-A20C2E63950BQ46082217-D9F00AE4-D822-4E06-91A5-A5DC3336E911Q46570350-736DAEBE-AAC5-45B9-8986-889926E15E71Q46807641-614C36EA-44D6-465D-BE54-2CE4E306E652Q46954390-20B18EA0-C476-4B4F-8AD0-A61D8D354C50Q47206849-43EFB9F4-DDDD-4136-838B-934A2E7B842BQ51482811-CB4D796B-6D8B-4D98-AA19-66A11BA9F943Q55396723-28753A72-7F33-44C3-91EC-07910AFFD848Q58880651-6D458649-335B-45A4-AABB-E9D1F6B59AE5
P2860
Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Influence of gender and oral c ...... activity in healthy volunteers
@ast
Influence of gender and oral c ...... activity in healthy volunteers
@en
Influence of gender and oral c ...... activity in healthy volunteers
@nl
type
label
Influence of gender and oral c ...... activity in healthy volunteers
@ast
Influence of gender and oral c ...... activity in healthy volunteers
@en
Influence of gender and oral c ...... activity in healthy volunteers
@nl
prefLabel
Influence of gender and oral c ...... activity in healthy volunteers
@ast
Influence of gender and oral c ...... activity in healthy volunteers
@en
Influence of gender and oral c ...... activity in healthy volunteers
@nl
P2860
P1476
Influence of gender and oral c ...... activity in healthy volunteers
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.2001.01328.X
P407
P50
P577
2001-02-01T00:00:00Z